← Back to patent-cliff list
CAS 578-46-1
5-methyl-2-nitroaniline
Codes: E-7820-001
Application context (from source-drug indications)
Myelodysplastic syndromeE-7820Acute myeloid leukaemiaE-7820Chronic myelomonocytic leukaemiaE-7820Colorectal cancerE-7820Colon cancerE-7820Rectal cancerE-7820
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| E-7820 | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
5-methyl-2-nitroaniline→ethyl 2-methyl-3-oxobutanoate→ethyl (E)-2-(2-(5-methyl-2-nitrophenyl)hydrazineylidene)propanoate→ethyl 4-methyl-7-nitro-1H-indole-2-carboxylate→4-methyl-7-nitro-1H-indole-2-carboxylic acid→4-methyl-7-nitro-1H-indole→4-methyl-7-nitro-1H-indole-3-carbaldehyde→4-methyl-7-nitro-1H-indole-3-carbonitrile→7-amino-4-methyl-1H-indole-3-carbonitrile→3-cyanobenzenesulfonyl chloride
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.